LAX.SH
CHEMFAB ALKALIS LIMITED·CHEMICALS 57.95·Chemicals & Petrochemicals Companies
Price
319.1
-3.04%52W Range
Market Cap
₹458.66 Cr
Traded: ₹0.03 Cr (0.01%) 0.0x
Free Float: ₹113.66 Cr (0.03% of FF traded)
Volume · 60D trend
1.06 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +11.0% | -2.0% | -- | -7.0% | Decelerating |
| Profit | -- | +10.0% | -- | -- | -138.0% | Decelerating |
| Return | -- | +23.0% | +14.0% | -50.0% | -- | Decelerating |
| ROE | -- | +7.0% | +3.0% | -- | -- | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 73 | 75 | 68 | 77 | 92 | 92 | 84 | 82 | 77 | 82 | 86 | 80 | 79 | 73 | 84 |
| Expenses | 63 | 66 | 66 | 71 | 80 | 79 | 72 | 72 | 68 | 70 | 71 | 69 | 64 | 49 | 59 |
| Operating Profit | 10 | 9 | 2 | 5 | 11 | 13 | 12 | 10 | 8 | 12 | 15 | 11 | 15 | 25 | 25 |
| Other Income | 2 | 3 | 3 | 2 | 1 | -9 | 3 | 1 | 3 | 2 | 2 | 1 | 4 | 2 | 2 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 8 | 8 | 7 | 7 | 6 | 11 | 10 | 9 | 7 | 6 | 5 | 6 | 5 | 5 | 6 |
| Profit Before Tax | 2 | 1 | -5 | -1 | 5 | -7 | 4 | 1 | 3 | 8 | 11 | 7 | 14 | 21 | 21 |
| Tax % | -158.1% | 60.2% | -7.1% | 51.1% | 45.7% | 25.0% | 48.1% | 172.6% | 66.7% | 32.0% | 34.4% | 35.4% | 30.6% | 25.6% | 29.4% |
| Net Profit | 6 | 0 | -4 | -2 | 3 | -9 | 2 | -1 | 1 | 5 | 7 | 4 | 10 | 15 | 15 |
| Exceptional Items | 0 | 0 | 0 | 0 | 0 | -10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 4.0 | 0.3 | -3.1 | -1.4 | 1.8 | -6.4 | 1.3 | -0.4 | 0.6 | 3.8 | 5.0 | 3.0 | 6.7 | 10.8 | 10.6 |
| Sales Growth (YoY) | -- | -19.0% | -18.5% | -6.5% | 19.6% | 12.2% | -3.1% | 2.9% | -3.2% | 12.3% | 2.9% | 4.7% | -19.4% | -16.8% | -- |
| Sales Growth (QoQ) | -- | 9.7% | -11.0% | -16.4% | -0.8% | 10.4% | 2.1% | 7.0% | -7.0% | -4.7% | 8.5% | 0.6% | 7.9% | -12.7% | -- |
| OP Growth (YoY) | -10.4% | -36.1% | -83.8% | -46.2% | 35.7% | 8.2% | -21.6% | -6.7% | -46.2% | -49.7% | -38.5% | -- | -- | -- | -- |
| OP Growth (QoQ) | 18.9% | 341.5% | -64.7% | -51.7% | -15.3% | 12.0% | 17.3% | 21.8% | -32.4% | -18.9% | 39.7% | -29.8% | -36.9% | -0.8% | -- |
| Profit Growth (YoY) | 125.0% | 142.0% | -337.0% | -279.0% | 183.0% | -121.0% | -74.0% | -112.0% | -91.0% | -65.0% | -52.0% | -72.0% | -55.0% | 19.0% | 24.0% |
| EPS Growth (YoY) | -- | 105.2% | -334.9% | -278.4% | 182.5% | -268.4% | -73.5% | -112.2% | -90.6% | -64.7% | -52.8% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 110.7% | -121.4% | -178.7% | 127.8% | -584.9% | 456.8% | -158.7% | -83.4% | -23.9% | 64.7% | -54.8% | -37.7% | 1.9% | -- |
| OP Margin | -- | 11.4% | 2.8% | 7.1% | 12.3% | 14.4% | 14.2% | 12.4% | 10.9% | 15.0% | 17.6% | 13.7% | 19.6% | 33.5% | 29.4% |
| Net Margin | -- | 0.6% | -6.5% | -2.6% | 2.8% | -9.9% | 2.3% | -0.7% | 1.2% | 6.6% | 8.2% | 5.4% | 12.0% | 20.8% | 17.8% |
| Material Cost % | 29.0% | 30.5% | 33.5% | 34.5% | 33.8% | 31.4% | 31.0% | 28.0% | 28.5% | 30.7% | 33.9% | 27.5% | 27.4% | 20.4% | 19.8% |
| Employee Cost % | 9.1% | 8.4% | 9.7% | 9.1% | 7.0% | 6.7% | 7.5% | 8.4% | 8.1% | 6.8% | 6.8% | 8.7% | 6.3% | 5.5% | 5.9% |
| P/S | 1.57 | 1.75 | 1.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.22 | 1.45 | 1.64 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2026 ,inter alia, to consider and approve The Un-Audited Standalone and ....
Submission of certificate under Reg 74(5) received from Cameo Corporate Services Ltd for the qtr ended 30th September 2026
Submission of Credit Rating Letter issued by India Ratings and Research (Ind-Ra) with respect to Company''s Bank loan facilities
Submission of letter for intimating the closure of trading window period wef 01st October 2026 till the expiry of 48 hours after the announcement of the Un-Audited Standalone and Consolidated ....
We wish to inform you that copy of the voting results along with the report of scrutinizer for the Annual General Meeting of the company held on 09th September 2026
Submission of initmation of appointment of Statutory Auditors at AGM of the Company.
Submission of summary of AGM proceedings held on 9th September, 2026 at 10 AM
Submission of Newspaper clippings for publication of notice of 17th AGM scheduled to be held on 09th September 2026 at 10:00 AM (IST)
Revised copy of AGM notice due to typo errors in the special business set out in the previously submitted AGM Notice.
Submission of Revised notice of AGM which forms part of Annual Report for FY 2025-26 due typographical error in the serial numbers of Special Business as set out in the notice of AGM.
Submission of correspondence(s) sent to shareholders whose E-mail ID are not registered with Company/RTA/DP for accsessing the Annual Report of FY 2025-26
Submission of Intimation of Record date, for payment of dividend, as 02.09.2026
Submission of Annual Report for FY 2025-26
Submission of notice of AGM scheduled to be held on 09th September 2026
Submission of unaudited financial results for the quarter ended 30th June, 2026
Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve The Un-Audited Standalone and ....
Submission of copies of newspaper advertisement on Notice of transfer of shares to IEPFA
Submission of certificate under Reg 74(5) received from Cameo Corporate Services Ltd for the qtr ended 30th June, 2026.
Submission of Letter for intimating the closure of trading window period w.e.f 1st July 2026 till the expiry of 48 hours after the announcement of the Un-Audited Standalone and Consolidated ....
Submission of copies of newspaper advertisement on Notice of transfer of shares to IEPFA.
Submission of copy of newspaper publication wrt. SEBI circular dated 30th Jan 2026 on special window for transfer and dematerialisation of physical securities.
Dear Sir/Mam, Please find enclosed Annual Secretarial Compliance Report for the financial Year ended 31st March 2026
Submission of Letter dated 20th May 2026 regarding investment by the Company in Zenataris Renewable Energy Private Limited. Kindly take the same on record.
Submission of newspaper clipping of Audited standalone and consolidated financial results for the quarter and financial year ended 31st March, 2026 approved by the Board on 13th May 2026 ....
Submission of investor presentation for the quarter and financial year ended 31st March 2026
The Board meeting held today i.e., 13th May, 2026 has approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2026 as recommended by ....
The Board Meeting held today i. e 13th May 2026 has approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March 2026.
The Board Meeting held today i.e 13th May 2026, The Board has approved the recommendation of dividend of Rs. 1.25/- per equity share to the shareholders.
In the Board Meeting held today i.e 13th May, 2026, The Board approved Re-appointment of M/s. Madhavan, Mohan & Associates, Cost Accountants as Cost Auditors and M/s. Brahmayya & Co, Chartered ....
Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve We wish to inform you that ....
Submission of certificate under Reg 74(5) received from Cameo Corporate Services Ltd for the qtr ended 31st March 2026
Submission of Letter for intimating the closure of trading window period w.e.f. 1st April 2026 till the expiry of 48 hours after the announcement of the Audited Standalone and Consolidated ....
Submission of Credit Rating Letter issued by India Ratings and Research (Ind-Ra) in respect of the Company''s banking facilities.
Submission of newspaper clippings on publication of unaudited financial results for the quarter and nine months ended 31st December, 2025
Submission of investor presentation for the quarter ended 31st December, 2025
Dear Sir, Due to technical glitch the unaudited financial results in the results module couldnt be uploaded within prescribed time slot. The same was filed as part of outcome in prescribed ....
The Board meeting held today i.e., 28th January, 2026 has approved the Un-Audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31°'' December, 2025 ....
Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and approve Board Meeting Intimation - ....
Submission of certificate received from RTA for compliance under Reg. 74(5) of SEBI (DP) Regulation, 2018.
Submission of intimation that the Company has successfully commissioned the latest generation INEOS Electrolyser replacing existing 30year old 2nd generation UHDE Electrolyser and associated ....
Submission of letter for closure of trading window
Intimation of change in name of the Wholly Owned Subsidiary - " CHEMFAB ALKALIS KARAIKAL LIMITED" to "CHEMFAB KARAIIKAL LIMITED" w.e.f. 3rd December 2025.
Submission of restated trading plan wrt clarity price action based execution.
Submission of amended policy on prevention and prohibition of Insider Trading in the Company approved vide Board Meeting held on 31st October, 2025.
Submission of newspaper clippings on publication of unaudited financial results for the quarter and half year ended 30.09.2025
Submission of investor presentation for quarter ended 30th September 2025 for your reference.
Submission of Initmation of allotment of ESOP under CAESOS 2020 at Board meeting held on 31st October, 2025
Dear Sir/Madam, Please find the attached unaudited financial results for the quarter and half year ended on 30th September,2025 for your reference
Dear Sir/Madam, We wish to inform you that the outcome of the board meeting held on 31st October,2025 for the financial results for the period ended September 30, 2025.
Chemfab Alkalis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and approve Unaudited Financial Results ....
Annual Reports
15Credit Ratings
6